Proposed Rule2023-00671
Petition for Rulemaking of Jonathan Askin, Professor of Clinical Law, Brooklyn Law School
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 17, 2023
Issuing agencies
Federal Trade Commission
Abstract
Please take notice that the Federal Trade Commission ("Commission") received a petition for rulemaking from Jonathan Askin, Professor of Clinical Law, Brooklyn School, and has published that petition online at https://www.regulations.gov. The Commission invites written comments concerning the petition. Publication of this petition is pursuant to the Commission's Rules of Practice and Procedure, and does not affect the legal status of the petition or its final disposition.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 10 (Tuesday, January 17, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 10 (Tuesday, January 17, 2023)]
[Proposed Rules]
[Pages 2562-2563]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-00671]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
16 CFR Part 1
[File No. R307001]
Petition for Rulemaking of Jonathan Askin, Professor of Clinical
Law, Brooklyn Law School
AGENCY: Federal Trade Commission.
ACTION: Receipt of petition; request for comment.
-----------------------------------------------------------------------
SUMMARY: Please take notice that the Federal Trade Commission
(``Commission'') received a petition for rulemaking from Jonathan
Askin, Professor of Clinical Law, Brooklyn School, and has published
that petition online at <a href="https://www.regulations.gov">https://www.regulations.gov</a>. The Commission
invites written comments concerning the petition. Publication of this
petition is pursuant to the Commission's Rules of Practice and
Procedure, and does not affect the legal status of the petition or its
final disposition.
DATES: Comments must identify the petition docket number and be filed
by February 16, 2023.
ADDRESSES: You may view the petition, identified by docket number FTC-
2023-0002, and submit written comments concerning its merits by using
the Federal eRulemaking Portal at <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Follow
the online instructions for submitting comments. Do not submit
sensitive or confidential information. You may read background
documents or comments received at <a href="https://www.regulations.gov">https://www.regulations.gov</a> at any
time.
FOR FURTHER INFORMATION CONTACT: Daniel Freer, Office of the Secretary,
Federal Trade Commission, 600 Pennsylvania Avenue NW, Washington, DC
20580, <a href="/cdn-cgi/l/email-protection#53373521363621133527307d343c25"><span class="__cf_email__" data-cfemail="c3a7a5b1a6a6b183a5b7a0eda4acb5">[email protected]</span></a>, (202) 326-2663.
SUPPLEMENTARY INFORMATION: Pursuant to Section 18(a)(1)(B) of the
Federal Trade Commission Act, 15 U.S.C. 57a(1)(B), and FTC Rule
1.31(f), 16 CFR 1.31(f), notice is hereby given that the above-
captioned petition has been filed with the Secretary of the Commission
and has been placed on the public record for a period of thirty (30)
days. Any person may submit comments in support of or in opposition to
the petition. All timely and responsive comments submitted in
connection with this petition will become part of the public record.
The Commission will not consider the petition's merits until after the
comment period closes.
Because your comment will be placed on the publicly accessible
website at <a href="https://www.regulations.gov">https://www.regulations.gov</a>, you are solely responsible for
making sure your
[[Page 2563]]
comment does not include any sensitive or confidential information. In
particular, your comment should not include any sensitive personal
information, such as your or anyone else's Social Security number; date
of birth; driver's license number or other state identification number,
or foreign country equivalent; passport number; financial account
number; or credit or debit card number. You are also solely responsible
for making sure your comment does not include any sensitive health
information, such as medical records or other individually identifiable
health information. In addition, your comment should not include any
``trade secret or any commercial or financial information which . . .
is privileged or confidential''--as provided by Section 6(f) of the FTC
Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2).
Authority: 15 U.S.C. 46; 15 U.S.C. 57a; 5 U.S.C. 601 note.
April J. Tabor,
Secretary.
[FR Doc. 2023-00671 Filed 1-13-23; 8:45 am]
BILLING CODE 6750-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 17, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.